Google
 

Archive for the ‘Alzheimer's / Dementia’ Category

Alzheimer’ S Society Comment On A Review Of Palliative Care Published In The May Issue Of Journal Of Clinical Nursing, UK

Thursday, May 15th, 2008

One in three people over 65 will die with dementia and too many of them are subjected to an undignified and unnecessarily painful death. This is often because staff lack the specialist training to provide good care at the end of someone's life. It is vital that all people, not ...

Weight Link To Dementia

Thursday, May 15th, 2008

"Obesity doubles the risk of Alzheimer's" is the headline in the Daily Express. It and other news sources report new research which found that people who are obese have an increased risk of all types of dementia. Being underweight "increased the risk of any kind of dementia by 36 per ...

Court Of Appeal Makes Decision Following Ruling That Nice Process On Anti-Dementia Medicines Unfair, UK

Thursday, May 15th, 2008

Eisai Limited, the licence holder of Aricept® (donepezil hydrochloride) and Pfizer Limited, its co-promotion partner, announced today that the Court of Appeal has released its decision on the consequential issues arising from Court of Appeal's recent ruling that the process by which the National Institute for Health and Clinical Excellence ...

Patent Claims Allowed Covering Samaritan’s Alzheimer’s Memory Recovery Drug In Australia

Thursday, May 15th, 2008

Samaritan Pharmaceuticals (OTCBB:SPHC), a biopharmaceutical company committed to commercializing new innovative therapeutic drugs, has received notification that the claims in the patent application for "Neuroprotective Spirostenol Pharmaceutical Compositions" covering Caprospinol (SP-233) have been allowed by the Australian Patent Office. The hallmark of Alzheimer's disease is plaque formation in areas ...

Anti-Inflammatory Drug - Alzheimer’s Society Comment

Thursday, May 15th, 2008

Alzheimer's Society comment on new research suggesting tarenflurbil may be effective in halting symptoms of Alzheimer's disease, from the Lancet Neurology. 'This exciting clinical trial suggests a modification of a safe and readily available anti-inflammatory drug has a positive impact on memory and function for people with mild Alzheimer's disease. ...

Alzheimer Scotland Supports Appeal Judgment On NICE Cost-effectiveness Disclosure

Thursday, May 15th, 2008

The Court of Appeal ruled in favour of the drug companies Pfizer and Eisai, by finding that the National Institute for Health and Clinical Excellence (NICE) should have allowed public access to the health economics model used to determine the cost-effectiveness of key treatments in people with early stage Alzheimer's. ...

Arthritis Drug Success With Alzheimer’s Prompts Calls For More Investment In Research

Friday, April 11th, 2008

A private clinic in California, USA, appears to be getting dramatic reductions in dementia symptoms by injecting an arthritis drug called etanercept into the neck of Alzheimer's patients. Using the drug as an "off-label" treatment (that is the drug is approved by the US Food and Drug Administration, but not ...

Three Winners Of New Award For Younger Researchers Announced By Coalition Of Alzheimer Organizations

Friday, April 11th, 2008

A coalition of leading Alzheimer's disease organizations today announced the first three recipients of "Tomorrow's Leaders in Alzheimer's Disease Research" prizes; a new award mechanism to recognize outstanding young scientists in Alzheimer's and dementia research. The three winners are: - Sterling C. Johnson, Ph.D. - Associate Professor of Medicine ...

Alzheimer’s Society Comment On Entanercept And TNF Alpha Protein, UK

Friday, April 11th, 2008

There is an urgent demand for treatments to tackle Alzheimer's disease, which affects 400,000 people in the UK and millions more carers. These numbers are rising and investment in dementia research is an essential part of confronting this devastating condition. On the surface these results are exciting but we need ...

Alzheimer’s Foundation Of America Symposium: Identifying Young-Onset Alzheimer’s Disease

Friday, April 11th, 2008

They are too young to forget the faces of loved ones. They are too young for missed appointments and shattered memories. They are too young for Alzheimer's disease. But maybe not. While Alzheimer's has long been associated with old age, new evidence is mounting that the disease can and does ...

Insulin Problems In Mid Life Linked To Raised Alzheimer’s Risk

Thursday, April 10th, 2008

A new study on men living in Sweden suggests that a poor insulin response in midlife, the main characteristic of diabetes, is linked to an increased risk of developing Alzheimer's disease up to 35 years later.The study is published in the early online 9th April issue of Neurology ...

Normal “Senior Moments,” Or Alzheimer’s Disease?

Thursday, April 10th, 2008

The recent passing of vibrant actor Charlton Heston from late-stage Alzheimer's disease makes us all stop and think about our own mortality. In particular, it is natural to wonder about your own memory, and what is 'normal' when it comes to memory loss as a result of aging.Occasional memory lapses, ...

Alzheimer’s Society Comment On Award For Ground-Breaking Dementia Documentary

Monday, April 7th, 2008

We are thrilled to hear Malcolm & Barbara: Love's Farewell has been named best single documentary at the 34th Broadcasting Press Guild Television and Radio Awards. When Malcolm Pointon was diagnosed with Alzheimer's disease, he and his wife Barbara made the decision to allow a camera to follow them up ...

How Telecare Helps Dementia Sufferers To Stay Living At Home, UK

Thursday, April 3rd, 2008

Dementia currently affects 700,000 people in the UK - and it is estimated that 150,000 of these live alone. Many people with dementia live in their own home but rely on support from an older carer, who may have their own ...

Alzheimer’s Society Comment On Paul Burstow MP’s Report On The Use Of Antipsychotics In People With Dementia, UK

Wednesday, April 2nd, 2008

The overprescribing of antipsychotics to people with dementia is robbing people of their quality of life and is a serious breach of human rights. Paul Burstow MP's report illustrates the scale and severity of the important issue. Inappropriate use of antipsychotics in people with dementia can cause devastating side effects, ...